Sci/Tech Stem-Cell firms surge as Obama fuels funding hopes

[South-Titan]

BANGALORE (Reuters) - Shares of companies developing therapies based on stem cells surged on Monday, after confirmation over the weekend that U.S. president-elect Barack Obama plans to reverse an existing executive order against federal funding of embryonic stem-cell research.

Companies such as Geron Corp and StemCells Inc saw a sharp rise in their stock price as investors rushed to be a part of a field that holds significant commercial potential.

Read more at: http://www.reuters.com/article/vcCandidateFeed2/idUSTRE4AA00920081111